MR-guided cardiac mapping platform reaches U.S. market
NorthStar is a cardiac mapping and guidance platform designed for real-time MR-guided interventional procedures.
Imricor Medical Systems has launched the NorthStar Mapping System commercially in the U.S. The system is a cardiac mapping and guidance platform designed for use with real-time MR imaging.
The company said the platform allows physicians to visualize the heart’s structure and tissue characteristics during minimally invasive interventional procedures. Imricor said the system does not require X-ray imaging.
The FDA’s 510(k) summary describes the technology as a system for interventional cardiovascular magnetic resonance imaging procedures, including electrophysiology procedures.
The system can display real-time MR images, 3D anatomical representations, interventional device location, electroanatomical maps, and ablation points, according to the FDA summary.
Imricor said the cardiac mapping platform differs from conventional MRI workflows by allowing real-time image viewing and manipulation during procedures. The company described it as built specifically for MR-guided interventional procedures.
The product page states that the system provides real-time visibility of anatomy, catheters, and lesion formation during cardiac ablations performed inside the MRI suite.
The NorthStar Mapping System has FDA clearance and CE mark, according to Imricor. The company noted that some other products in its interventional MR portfolio have CE mark approval but have not yet been approved for U.S. use.
Imricor said it planned to show the system at the Heart Rhythm Society Annual Scientific Sessions, which began April 24 in Chicago.
Company:Imricor
About the author
RadiologySignal.com writersEditorial Team
Radiology Signal Staff covers developments across medical imaging, radiology AI, imaging informatics, clinical research, and radiology business. The team monitors primary sources, peer-reviewed studies, company announcements, society updates, and healthcare industry news to deliver concise reporting for imaging professionals.
More from this section
Niowave Lansing site to scale Ac-225 supply by 2028
The Lansing, MI, site will house superconducting linear accelerators and radiochemistry systems to support scalable actinium-225 production, with completion expected in 2028.
GE HealthCare, UW Medicine launch imaging research collaboration
The collaboration will focus on CT and molecular imaging technologies for cardiology, oncology, and theranostics workflows at UW Medicine Radiology facilities in Seattle.
Recall issues and isotope shortages weigh on Radnostix Q1 revenue
The radioisotope-focused company reported $2.38M in Q1 revenue, citing recall impacts, isotope shortages, and Cobalt-60 hot cell downtime.
Ephemeral to build AI data platform for Plus CNS oncology programs
The companies will develop an AI platform to integrate therapeutic, diagnostic, and bioinformatics data across Plus Therapeutics’ CNS oncology programs.
Fujifilm launches balloon-less EBUS bronchoscope
The EB-710US Ultrasound Bronchoscope is designed for pulmonary procedures and will be demonstrated at the American Thoracic Society Conference.
ACIST wins FDA clearance for Pro Diagnostic System
The Bracco company received U.S. clearance and launched ACIST Pro, a variable-rate contrast management system for image-guided cardiovascular procedures.
Braid Health launches $199 radiology second-opinion service
Patients can upload MRI, CT, X-ray, or ultrasound files and receive a written second opinion from a board-certified U.S. radiologist.
QT Imaging prices $10M raise for breast imaging platform
QT Imaging Holdings priced a $10M underwritten public offering of common stock and pre-funded warrants. The breast imaging technology company plans to use proceeds for working capital and general corporate purposes.
PSMA PET guidance anchors EDAP-Telix HIFU prostate work
EDAP TMS and Telix Pharmaceuticals signed a letter of intent to explore clinical research combining Focal One Robotic HIFU with Telix PSMA PET imaging agents in prostate cancer care.
UnitedHealthcare cites radiology costs in Maryland premium request
UnitedHealthcare is seeking an average 7.9% mid-year premium increase for some Maryland small-group plans. The insurer cited rising outpatient costs, including radiology, lab pathology, infusion, and radiation therapy.
Lumexa adds 4 imaging centers, including first UPMC JV site
Lumexa Imaging added 4 outpatient imaging centers across Pennsylvania, North Carolina, South Carolina, and Florida. The expansion includes acquired centers through joint ventures with UPMC and Advocate Health, plus 2 newly built locations.
PAI report finds 82% of U.S. physicians are now employed
A new PAI-Avalere report found that 82% of U.S. physicians are employed by hospitals, health systems, or corporate entities. Physician-owned settings now account for 18% of physicians and 36.1% of practices.